Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Draft Genome Sequences of Staphylococcus Podophages JBug18, Pike, Pontiff, and Pabna.

Culbertson EK, Bari SMN, Dandu VS, Kriznik JM, Scopel SE, Stanley SP, Lackey K, Hernandez AC, Hatoum-Aslan A.

Microbiol Resour Announc. 2019 Feb 21;8(8). pii: e00054-19. doi: 10.1128/MRA.00054-19. eCollection 2019 Feb.

2.

CRISPR-Cas10 assisted editing of virulent staphylococcal phages.

Nayeemul Bari SM, Hatoum-Aslan A.

Methods Enzymol. 2019;616:385-409. doi: 10.1016/bs.mie.2018.10.023. Epub 2018 Dec 17.

PMID:
30691652
3.

CRISPR Methods for Nucleic Acid Detection Herald the Future of Molecular Diagnostics.

Hatoum-Aslan A.

Clin Chem. 2018 Dec;64(12):1681-1683. doi: 10.1373/clinchem.2018.295485. Epub 2018 Oct 15. No abstract available.

PMID:
30323083
4.

Phage Genetic Engineering Using CRISPR⁻Cas Systems.

Hatoum-Aslan A.

Viruses. 2018 Jun 19;10(6). pii: E335. doi: 10.3390/v10060335. Review.

5.

Strategies for Editing Virulent Staphylococcal Phages Using CRISPR-Cas10.

Bari SMN, Walker FC, Cater K, Aslan B, Hatoum-Aslan A.

ACS Synth Biol. 2017 Dec 15;6(12):2316-2325. doi: 10.1021/acssynbio.7b00240. Epub 2017 Sep 21.

6.

Expression and Purification of the Cas10-Csm Complex from Staphylococci.

Chou-Zheng L, Hatoum-Aslan A.

Bio Protoc. 2017 Jun 5;7(11). pii: e2353. doi: 10.21769/BioProtoc.2353.

7.

Conjugation Assay for Testing CRISPR-Cas Anti-plasmid Immunity in Staphylococci.

Walker FC, Hatoum-Aslan A.

Bio Protoc. 2017 May 5;7(9). pii: e2293. doi: 10.21769/BioProtoc.2293.

8.

A Novel Staphylococcus Podophage Encodes a Unique Lysin with Unusual Modular Design.

Cater K, Dandu VS, Bari SM, Lackey K, Everett GF, Hatoum-Aslan A.

mSphere. 2017 Mar 22;2(2). pii: e00040-17. doi: 10.1128/mSphere.00040-17. eCollection 2017 Mar-Apr.

9.

Molecular determinants for CRISPR RNA maturation in the Cas10-Csm complex and roles for non-Cas nucleases.

Walker FC, Chou-Zheng L, Dunkle JA, Hatoum-Aslan A.

Nucleic Acids Res. 2017 Feb 28;45(4):2112-2123. doi: 10.1093/nar/gkw891.

10.

Co-transcriptional DNA and RNA Cleavage during Type III CRISPR-Cas Immunity.

Samai P, Pyenson N, Jiang W, Goldberg GW, Hatoum-Aslan A, Marraffini LA.

Cell. 2015 May 21;161(5):1164-1174. doi: 10.1016/j.cell.2015.04.027. Epub 2015 May 7.

11.

Impact of CRISPR immunity on the emergence and virulence of bacterial pathogens.

Hatoum-Aslan A, Marraffini LA.

Curr Opin Microbiol. 2014 Feb;17:82-90. doi: 10.1016/j.mib.2013.12.001. Epub 2013 Dec 29. Review.

12.

Genetic characterization of antiplasmid immunity through a type III-A CRISPR-Cas system.

Hatoum-Aslan A, Maniv I, Samai P, Marraffini LA.

J Bacteriol. 2014 Jan;196(2):310-7. doi: 10.1128/JB.01130-13. Epub 2013 Nov 1.

13.

A ruler protein in a complex for antiviral defense determines the length of small interfering CRISPR RNAs.

Hatoum-Aslan A, Samai P, Maniv I, Jiang W, Marraffini LA.

J Biol Chem. 2013 Sep 27;288(39):27888-97. doi: 10.1074/jbc.M113.499244. Epub 2013 Aug 9.

14.

CRISPR decoys: competitive inhibitors of CRISPR immunity.

Maniv I, Hatoum-Aslan A, Marraffini LA.

RNA Biol. 2013 May;10(5):694-9. doi: 10.4161/rna.24287. Epub 2013 Apr 12.

15.

CRISPR interference can prevent natural transformation and virulence acquisition during in vivo bacterial infection.

Bikard D, Hatoum-Aslan A, Mucida D, Marraffini LA.

Cell Host Microbe. 2012 Aug 16;12(2):177-86. doi: 10.1016/j.chom.2012.06.003.

16.

Mature clustered, regularly interspaced, short palindromic repeats RNA (crRNA) length is measured by a ruler mechanism anchored at the precursor processing site.

Hatoum-Aslan A, Maniv I, Marraffini LA.

Proc Natl Acad Sci U S A. 2011 Dec 27;108(52):21218-22. doi: 10.1073/pnas.1112832108. Epub 2011 Dec 12.

Supplemental Content

Loading ...
Support Center